(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE decreases expression EXP 6480464 Topotecan results in decreased expression of KIF2C mRNA CTD PMID:25729387 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KIF2C mRNA CTD PMID:25729387 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of KIF2C mRNA CTD PMID:12832660 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of KIF2C mRNA CTD PMID:30723492 17alpha-ethynylestradiol multiple interactions ISO RGD:734429 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF2C mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of KIF2C mRNA CTD PMID:17351261 17beta-estradiol increases expression ISO RGD:734428 6480464 Estradiol results in increased expression of KIF2C mRNA CTD PMID:18310284 , PMID:19167446 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of KIF2C mRNA CTD PMID:26372666 17beta-estradiol increases expression ISO RGD:734429 6480464 Estradiol results in increased expression of KIF2C mRNA CTD PMID:25210133 17beta-estradiol multiple interactions ISO RGD:734429 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of KIF2C mRNA] CTD PMID:25210133 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:734429 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:734429 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:734429 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF2C mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:734429 6480464 Tetrachlorodibenzodioxin affects the expression of KIF2C mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:734429 6480464 Tetrachlorodibenzodioxin results in increased expression of KIF2C mRNA CTD PMID:19770486 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:734428 6480464 2 more ... CTD PMID:19031421 2,4-diaminotoluene increases expression ISO RGD:734429 6480464 2, 4-diaminotoluene results in increased expression of KIF2C mRNA CTD PMID:20713471 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione multiple interactions ISO RGD:734428 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of KIF2C mRNA CTD PMID:18720364 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:734428 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of KIF2C mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KIF2C mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO RGD:734429 6480464 Methylcholanthrene results in increased expression of KIF2C mRNA CTD PMID:20713471 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of KIF2C mRNA CTD PMID:26372666 4,4'-sulfonyldiphenol multiple interactions ISO RGD:734428 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of KIF2C mRNA CTD PMID:28628672 5-azacytidine multiple interactions ISO RGD:734428 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of KIF2C mRNA CTD PMID:18720364 5-fluorouracil affects response to substance ISO RGD:734428 6480464 KIF2C protein affects the susceptibility to Fluorouracil CTD PMID:15548681 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of KIF2C mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:734428 6480464 Aflatoxin B1 affects the expression of KIF2C protein CTD PMID:20106945 all-trans-retinoic acid decreases expression ISO RGD:734428 6480464 Tretinoin results in decreased expression of KIF2C mRNA CTD PMID:16249480 antirheumatic drug decreases expression ISO RGD:734428 6480464 Antirheumatic Agents results in decreased expression of KIF2C mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:734429 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of KIF2C mRNA CTD PMID:23650126 azathioprine decreases expression ISO RGD:734428 6480464 Azathioprine results in decreased expression of KIF2C mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:734428 6480464 Benzo(a)pyrene results in decreased expression of KIF2C mRNA CTD PMID:20064835 benzo[a]pyrene decreases expression ISO RGD:734429 6480464 Benzo(a)pyrene results in decreased expression of KIF2C mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene increases expression ISO RGD:734429 6480464 Benzo(a)pyrene results in increased expression of KIF2C mRNA CTD PMID:20713471 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:734428 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bis(2-chloroethyl) sulfide decreases expression ISO RGD:734428 6480464 Mustard Gas results in decreased expression of KIF2C mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of KIF2C mRNA, Diethylhexyl Phthalate results in decreased expression of KIF2C protein CTD PMID:20920545 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KIF2C mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:734428 6480464 bisphenol A results in decreased expression of KIF2C mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:734428 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KIF2C mRNA CTD PMID:28628672 buta-1,3-diene increases expression ISO RGD:734429 6480464 1, 3-butadiene results in increased expression of KIF2C mRNA CTD PMID:29038090 cadmium atom increases expression ISO RGD:734428 6480464 Cadmium results in increased expression of KIF2C mRNA CTD PMID:19031421 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of KIF2C mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:734428 6480464 Calcitriol results in decreased expression of KIF2C mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:734428 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of KIF2C mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:734429 6480464 Nanotubes, Carbon analog results in increased expression of KIF2C mRNA, Nanotubes, Carbon results in increased expression of KIF2C mRNA CTD PMID:25554681 carmustine decreases expression EXP 6480464 Carmustine results in decreased expression of KIF2C mRNA CTD PMID:16005536 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of KIF2C mRNA CTD PMID:18500788 chloroprene increases expression ISO RGD:734429 6480464 Chloroprene results in increased expression of KIF2C mRNA CTD PMID:23125180 cis-caffeic acid multiple interactions ISO RGD:734428 6480464 caffeic acid inhibits the reaction [Thapsigargin results in increased expression of KIF2C mRNA] CTD PMID:19442820 cisplatin increases expression ISO RGD:734428 6480464 Cisplatin results in increased expression of KIF2C mRNA CTD PMID:27594783 cisplatin decreases expression ISO RGD:734428 6480464 Cisplatin results in decreased expression of KIF2C mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:734428 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of KIF2C mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:734428 6480464 cobaltous chloride results in decreased expression of KIF2C mRNA CTD PMID:19320972 , PMID:19376846 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of KIF2C mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:734428 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KIF2C mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:734428 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KIF2C mRNA CTD PMID:20971185 copper(2+) multiple interactions ISO RGD:734428 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KIF2C mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:734428 6480464 Copper Sulfate results in decreased expression of KIF2C mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:734428 6480464 Coumestrol results in increased expression of KIF2C mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:734428 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:734428 6480464 Cyclosporine results in decreased expression of KIF2C mRNA CTD PMID:20106945 more ... decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of KIF2C mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO RGD:734428 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of KIF2C mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KIF2C mRNA CTD PMID:28628672 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of KIF2C mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:734429 6480464 Dichloroacetic Acid results in increased expression of KIF2C mRNA CTD PMID:28962523 dorsomorphin multiple interactions ISO RGD:734428 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF2C mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:734428 6480464 Doxorubicin results in decreased expression of KIF2C mRNA CTD PMID:30031762 Enterolactone multiple interactions ISO RGD:734428 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF2C mRNA CTD PMID:19167446 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of KIF2C mRNA CTD PMID:24412560 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of KIF2C mRNA CTD PMID:24412560 furan increases expression EXP 6480464 furan results in increased expression of KIF2C mRNA CTD PMID:25539665 genistein affects expression ISO RGD:734428 6480464 Genistein affects the expression of KIF2C mRNA CTD PMID:18847459 geraniol decreases expression ISO RGD:734428 6480464 geraniol results in decreased expression of KIF2C mRNA CTD PMID:27683099 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of KIF2C mRNA CTD PMID:24395379 indometacin multiple interactions ISO RGD:734428 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of KIF2C mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KIF2C mRNA CTD PMID:28628672 isoflavones decreases expression ISO RGD:734428 6480464 Isoflavones results in decreased expression of KIF2C mRNA CTD PMID:17374662 leflunomide decreases expression ISO RGD:734428 6480464 leflunomide results in decreased expression of KIF2C mRNA CTD PMID:28988120 lucanthone decreases expression ISO RGD:734428 6480464 Lucanthone results in decreased expression of KIF2C mRNA CTD PMID:21148553 menadione affects expression ISO RGD:734428 6480464 Vitamin K 3 affects the expression of KIF2C mRNA CTD PMID:20044591 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of KIF2C mRNA CTD PMID:16005536 methyl methanesulfonate increases expression ISO RGD:734428 6480464 Methyl Methanesulfonate results in increased expression of KIF2C mRNA CTD PMID:23649840 N-nitrosodiethylamine increases expression ISO RGD:734429 6480464 Diethylnitrosamine results in increased expression of KIF2C mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:734429 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of KIF2C mRNA] CTD PMID:17854601 nickel atom increases expression ISO RGD:734428 6480464 Nickel results in increased expression of KIF2C mRNA CTD PMID:19031421 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KIF2C mRNA CTD PMID:25729387 palbociclib decreases expression ISO RGD:734428 6480464 palbociclib results in decreased expression of KIF2C mRNA CTD PMID:22869556 paracetamol increases expression ISO RGD:734428 6480464 Acetaminophen results in increased expression of KIF2C mRNA CTD PMID:22230336 paracetamol decreases expression ISO RGD:734428 6480464 Acetaminophen results in decreased expression of KIF2C mRNA CTD PMID:29067470 phenobarbital increases expression ISO RGD:734429 6480464 Phenobarbital results in increased expression of KIF2C mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:734428 6480464 Phenylmercuric Acetate results in decreased expression of KIF2C mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:734428 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF2C mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate increases expression ISO RGD:734428 6480464 Tetradecanoylphorbol Acetate results in increased expression of KIF2C mRNA CTD PMID:19031421 phytoestrogen increases expression ISO RGD:734428 6480464 Phytoestrogens results in increased expression of KIF2C mRNA CTD PMID:18310284 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of KIF2C mRNA CTD PMID:19162173 , PMID:22484513 piroxicam increases expression ISO RGD:734428 6480464 Piroxicam results in increased expression of KIF2C mRNA CTD PMID:21858171 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:734429 6480464 Pregnenolone Carbonitrile results in increased expression of KIF2C mRNA CTD PMID:22698814 propanal decreases expression ISO RGD:734428 6480464 propionaldehyde results in decreased expression of KIF2C mRNA CTD PMID:26079696 resveratrol multiple interactions ISO RGD:734428 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of KIF2C mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:734428 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF2C mRNA CTD PMID:27188386 silver atom decreases expression ISO RGD:734429 6480464 Silver results in decreased expression of KIF2C mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:734429 6480464 Silver results in decreased expression of KIF2C mRNA CTD PMID:27131904 silver(1+) decreases expression ISO RGD:734429 6480464 Silver results in decreased expression of KIF2C mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:734429 6480464 sodium arsenite results in decreased expression of KIF2C mRNA CTD PMID:17998272 sodium arsenite increases expression ISO RGD:734428 6480464 sodium arsenite results in increased expression of KIF2C mRNA CTD PMID:29301061 sophoraflavanone B increases expression EXP 6480464 8-prenylnaringenin results in increased expression of KIF2C mRNA CTD PMID:26372666 tert-butyl hydroperoxide increases expression ISO RGD:734429 6480464 tert-Butylhydroperoxide results in increased expression of KIF2C mRNA CTD PMID:15003993 testosterone multiple interactions ISO RGD:734428 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of KIF2C mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:734428 6480464 Testosterone results in decreased expression of KIF2C mRNA CTD PMID:21592394 tetrachloroethene increases expression ISO RGD:734428 6480464 Tetrachloroethylene results in increased expression of KIF2C mRNA CTD PMID:19031421 tetrachloromethane increases expression ISO RGD:734429 6480464 Carbon Tetrachloride results in increased expression of KIF2C mRNA CTD PMID:29987408 thalidomide multiple interactions ISO RGD:734428 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of KIF2C mRNA CTD PMID:18720364 thapsigargin multiple interactions ISO RGD:734428 6480464 4-methoxycinnamate methyl ester inhibits the reaction [Thapsigargin results in increased expression of KIF2C mRNA] more ... CTD PMID:19442820 thapsigargin increases expression ISO RGD:734428 6480464 Thapsigargin results in increased expression of KIF2C mRNA CTD PMID:19442820 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of KIF2C mRNA CTD PMID:22659510 , PMID:23411599 tioguanine decreases expression EXP 6480464 Thioguanine results in decreased expression of KIF2C mRNA CTD PMID:16005536 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KIF2C mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of KIF2C mRNA CTD PMID:25729387 trans-caffeic acid multiple interactions ISO RGD:734428 6480464 caffeic acid inhibits the reaction [Thapsigargin results in increased expression of KIF2C mRNA] CTD PMID:19442820 trimellitic anhydride increases expression ISO RGD:734429 6480464 trimellitic anhydride results in increased expression of KIF2C mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:734428 6480464 troglitazone results in decreased expression of KIF2C mRNA CTD PMID:19140230 valproic acid decreases expression ISO RGD:734429 6480464 Valproic Acid results in decreased expression of KIF2C mRNA CTD PMID:21427059 valproic acid affects expression ISO RGD:734428 6480464 Valproic Acid affects the expression of KIF2C mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:734428 6480464 Valproic Acid results in decreased expression of KIF2C mRNA CTD PMID:23179753 , PMID:28001369 zaragozic acid A decreases expression ISO RGD:734429 6480464 squalestatin 1 results in decreased expression of KIF2C mRNA CTD PMID:27225895 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of KIF2C mRNA CTD PMID:27225895 zinc atom increases expression ISO RGD:734428 6480464 Zinc deficiency results in increased expression of KIF2C mRNA CTD PMID:22171008 zinc(0) increases expression ISO RGD:734428 6480464 Zinc deficiency results in increased expression of KIF2C mRNA CTD PMID:22171008
Gene-Chemical Interaction Annotations
